Werewolf’s PREDATOR protein engineering technology creates biological prodrugs that remain inactive in the systemic circulation. These prodrugs are activated into immune stimulants only in the ...

“I am thrilled to join Werewolf’s board of directors as the company advances its novel INDUKINE molecules through clinical development,” said Dr. Singhal. “Werewolf is demonstrating the power of the ...